<?xml version="1.0" encoding="UTF-8"?>

<Composition xmlns="http://hl7.org/fhir">
  <id value="gravitate-Pedro"/>
  <text>
    <status value="extensions"/><div xmlns="http://www.w3.org/1999/xhtml">
  
    <b>Id:</b>
    gravitate-Pedro
  <br/>
  
    <b>status:</b>
    final
  <br/>
  
    <b>Type:</b>
    Patient summary Document
  <br/>
  
    <b>Subject:</b>
    <a>Pedro Gravitate</a>
  

  <br/>
  <b>Sections:</b>
  <br/>

  <ul>
    
      <li>

        Problem List

      </li>
      <ul>

        

          <li>

            HIV

          </li>
        

          <li>

            Depression

          </li>
        

          <li>

            IBS

          </li>
        
      </ul>

    
      <li>

        Medication Summary

      </li>
      <ul>

        

          <li>

            Dovato lamivudine and dolutegravir, 300 mg/50 mg

          </li>
        

          <li>

            Mirtazapine 15 mg

          </li>
        

          <li>

            Calcium carbonate 500 mg

          </li>
        

          <li>

            Cinitrapide 1 mg

          </li>
        

          <li>

            Collagen and magnesium supplements

          </li>
        

          <li>

            Vitamin C supplements

          </li>
        

          <li>

            Protein supplements

          </li>
        
      </ul>

    
  </ul>
</div>
  </text>
  <status value="final"/>
  <type>
    <coding>
      <system value="http://loinc.org"/>
      <code value="60591-5"/>
      <display value="Patient summary Document"/>
    </coding>
  </type>
  <subject>
    <reference value="Patient/pedro-patient"/>
    <display value="Pedro Gravitate"/>
  </subject>
  <date value="2018-07-10T15:22:00+02:00"/>
  <author>
    <reference value="Practitioner/pedro-pract"/>
    <display value="Dr. Anna Karlsson"/>
  </author>
  <title value="Patient Summary (Pedro Gravitate)"/>
  <confidentiality value="N"/>
  <section>
    <title value="Problem List"/>
    <code>
      <coding>
        <system value="http://loinc.org"/>
        <code value="11450-4"/>
        <display value="Problem list Reported"/>
      </coding>
    </code>
    <entry>
      <reference value="Condition/pedro-cond-1"/>
      <display value="HIV"/>
    </entry>
    <entry>
      <reference value="Condition/pedro-cond-2"/>
      <display value="Depression"/>
    </entry>
    <entry>
      <reference value="Condition/pedro-cond-3"/>
      <display value="IBS"/>
    </entry>
  </section>
  <section>
    <title value="Medication Summary"/>
    <code>
      <coding>
        <system value="http://loinc.org"/>
        <code value="10160-0"/>
        <display value="Hx of Medication use"/>
      </coding>
    </code>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-1"/>
      <display value="Dovato lamivudine and dolutegravir, 300 mg/50 mg"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-2"/>
      <display value="Mirtazapine 15 mg"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-3"/>
      <display value="Calcium carbonate 500 mg"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-4"/>
      <display value="Cinitrapide 1 mg"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-5"/>
      <display value="Collagen and magnesium supplements"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-6"/>
      <display value="Vitamin C supplements"/>
    </entry>
    <entry>
      <reference value="MedicationStatement/pedro-med-stat-7"/>
      <display value="Protein supplements"/>
    </entry>
  </section>
</Composition>